(Q39855654)

15 September 2017

Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2. (English)

1 reference

15 September 2017

N Gammoh

1

1 reference

15 September 2017

E Isaacson

2

1 reference

15 September 2017

V Tomaić

3

1 reference

15 September 2017

D J Jackson

4

1 reference

15 September 2017

J Doorbar

5

1 reference

15 September 2017

L Banks

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

4 May 2009

1 reference

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

23

1 reference

15 September 2017

2299-2304

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.78

15 September 2017

0 references

cites work

Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Crosstalk between the human papillomavirus E2 transcriptional activator and the E6 oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Association of bovine papillomavirus E2 protein with nuclear structures in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Interaction between the HPV-16 E2 transcriptional activator and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

Cancer genes and the pathways they control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by e6 siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.78

21 January 2018

Identifiers

DOI

10.1038/ONC.2009.78

1 reference

15 September 2017

1 reference